Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.
Zinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J, Cunningham D, Kline J, Johnson NA, Mehta-Shah N, Manley T, Francis S, Sharma M, Moskowitz AJ. Zinzani PL, et al. Among authors: moskowitz aj. J Clin Oncol. 2019 Nov 20;37(33):3081-3089. doi: 10.1200/JCO.19.01492. Epub 2019 Aug 9. J Clin Oncol. 2019. PMID: 31398081 Free PMC article. Clinical Trial.
Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma.
Moskowitz AJ, Perales MA, Kewalramani T, Yahalom J, Castro-Malaspina H, Zhang Z, Vanak J, Zelenetz AD, Moskowitz CH. Moskowitz AJ, et al. Among authors: moskowitz ch. Br J Haematol. 2009 Jul;146(2):158-63. doi: 10.1111/j.1365-2141.2009.07727.x. Epub 2009 May 12. Br J Haematol. 2009. PMID: 19438504 Free PMC article.
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.
Moskowitz CH, Yahalom J, Zelenetz AD, Zhang Z, Filippa D, Teruya-Feldstein J, Kewalramani T, Moskowitz AJ, Rice RD, Maragulia J, Vanak J, Trippett T, Hamlin P, Horowitz S, Noy A, O'Connor OA, Portlock C, Straus D, Nimer SD. Moskowitz CH, et al. Among authors: moskowitz aj. Br J Haematol. 2010 Mar;148(6):890-7. doi: 10.1111/j.1365-2141.2009.08037.x. Epub 2010 Jan 18. Br J Haematol. 2010. PMID: 20085577 Free PMC article. Clinical Trial.
Novel agents in Hodgkin lymphoma.
Moskowitz AJ. Moskowitz AJ. Curr Oncol Rep. 2012 Oct;14(5):419-23. doi: 10.1007/s11912-012-0251-y. Curr Oncol Rep. 2012. PMID: 22706966 Review.
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma.
Moskowitz AJ, Hamlin PA Jr, Perales MA, Gerecitano J, Horwitz SM, Matasar MJ, Noy A, Palomba ML, Portlock CS, Straus DJ, Graustein T, Zelenetz AD, Moskowitz CH. Moskowitz AJ, et al. Among authors: moskowitz ch. J Clin Oncol. 2013 Feb 1;31(4):456-60. doi: 10.1200/JCO.2012.45.3308. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248254 Free PMC article. Clinical Trial.
How I treat the peripheral T-cell lymphomas.
Moskowitz AJ, Lunning MA, Horwitz SM. Moskowitz AJ, et al. Blood. 2014 Apr 24;123(17):2636-44. doi: 10.1182/blood-2013-12-516245. Epub 2014 Mar 10. Blood. 2014. PMID: 24615779 Free PMC article. Review.
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.
Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL. Carson KR, et al. Among authors: moskowitz aj, moskowitz ch. Cancer. 2014 Aug 15;120(16):2464-71. doi: 10.1002/cncr.28712. Epub 2014 Apr 25. Cancer. 2014. PMID: 24771533 Free PMC article.
New frontiers for brentuximab vedotin for lymphomas.
Moskowitz AJ. Moskowitz AJ. Leuk Lymphoma. 2015 Feb;56(2):283-4. doi: 10.3109/10428194.2014.974050. Epub 2014 Nov 19. Leuk Lymphoma. 2015. PMID: 25315080 No abstract available.
252 results